California Pacific a State Leader for Volume of Simultaneous Pancreas Kidney Transplants
New Approaches to Organ Donation and Transplant
By William Bry, M.D., surgical director, Kidney Transplant Program and Laura Miyashita
For individuals with insulin-dependent (Type 1) diabetes and kidney failure, a simultaneous pancreas-kidney (SPK) transplant can restore one’s quality of life and eliminate the daily burden of insulin shots and blood glucose monitoring.
“Due to medical and surgical advances that have improved the success rate of pancreas transplant, we are providing this option to an increasing number of individuals,” says William Bry, M.D., surgical director of California Pacific Medical Center’s Kidney Transplant Program. He explains that a SPK transplant generally has a higher success rate than a pancreas after prior kidney transplant."
“Over the last year we performed 19 SPK transplants—the most in California during this period,” says Bry. “Within Northern California, data shows that both California Pacific and UCSF have the most active SPK transplant programs.”
In Northern California, individuals waiting for a SPK transplant have their name placed on the pancreas transplant waiting list. Then, once a pancreas donor becomes available, the individual receives both the pancreas and kidney from that donor.
California Pacific’s outcomes following SPK transplant are in alignment with national expectations for patient and graft survival. According to the Scientific Registry of Transplant Recipients (www.srtr.org), California Pacific’s one-year patient survival for SPK transplants is 98%. Graft survival at one-year is 94% for the transplanted kidney and 90% for the transplanted pancreas.
|Numbers of transplants||19||17||3||3|
|Number of candidates||94||86||9||9|